LNTH vs PRE vs HTFL Stock Comparison

Lantheus Holdings, Prenetics Global and Heartflow Prices as of Nov 3, 2026 Peers: Industry group
1 more company in this comparison (VREX) Create a free account to keep reading and compare up to 10 companies.
LNTH Lantheus Holdings, Inc.
$100.80 +0.8% 1M +77.4% 1Y
Market cap
$6.60B
P/E
24.0x
Revenue (TTM)
$1.56B
Div. yield
–
Diagnostic Equipment Healthcare
6 wins
PRE Prenetics Global Ltd
$16.19 -19.7% 1M +19.3% 1Y
Market cap
$225.11M
P/E
–
Revenue (TTM)
$185.92M
Div. yield
–
Diagnostic Equipment Healthcare
1 win
HTFL Heartflow, Inc.
$54.40 +10.3% 1M +59.8% 1Y
Market cap
$4.90B
P/E
–
Revenue (TTM)
$212.08M
Div. yield
–
Diagnostic Equipment Healthcare

Head to Head

7 decided of 12

Lantheus Holdings leads on 6 of the 12 questions below (Lantheus Holdings 6, Prenetics Global 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionLNTHPREHTFLLeader
Larger companyMarket capitalisation $6.60B $225.11M $4.90B LNTH
Cheaper on earningsLower P/E, profitable companies only 24.0x -3.2x -41.4x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 17.5x — — –
Faster revenue growthRevenue growth, trailing twelve months +2.3% +513.0% +42.8% PRE
More profitableNet margin, trailing twelve months 17.7% -38.2% -55.8% LNTH
Better return on capitalReturn on invested capital 12.5% — — –
Less leveragedLower net debt / EBITDA -0.1x — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +77.4% +19.3% +59.8% LNTH
Better 5-year returnAnnualised price return, 5 years +29.6%/yr -32.4%/yr — LNTH
Less volatileAnnualised volatility, 1 year 31.9% 79.8% 76.7% LNTH
Higher overall scoreMean of the five percentile scores vs peers 80/100 51/100 49/100 LNTH

Percentile Scorecard

LNTHPREHTFL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisLNTHPREHTFL
Valuation 80 #46 of 229 36 #147 of 229 27 #167 of 229
Growth 63 #83 of 221 68 #72 of 221 73 #61 of 221
Profitability 95 #12 of 209 42 #122 of 209 42 #121 of 209
Financial Health 71 #71 of 240 59 #98 of 240 84 #39 of 240
Shareholder Returns 94 #10 of 147 – 19 #119 of 147
Overall 80 51 49
  • LNTH ranked among 248 companies in Medical Devices and Diagnostics
  • PRE ranked among 248 companies in Medical Devices and Diagnostics
  • HTFL ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodLNTHPREHTFLSPY
1 month +0.8%-19.7%+10.3% -2.0%
3 months -0.3%-12.8%+99.4% -2.2%
6 months +17.5%-3.2%+81.6% +4.2%
Year to date +51.5%+2.8%+86.6% +10.6%
1 year +77.4%+19.3%+59.8% +10.4%
3 years +56.7%+237.3%— +73.6%
3 years, per year +16.2%+50.0%— +20.2%
5 years +265.9%-85.9%— +61.6%
5 years, per year +29.6%-32.4%— +10.1%
10 years +1,072.1%—— +261.3%
10 years, per year +27.9%—— +13.7%

Risk

MeasureLNTHPREHTFLSPY
Volatility, 1Y 31.9%79.8%76.7% 12.8%
Downside volatility, 1Y 27.3%73.6%77.6% 12.8%
Beta vs S&P 500, 1Y 0.571.621.91 1.00
Return / volatility, 1Y 2.430.240.78 0.81
Max drawdown, 5Y -59.5%-97.6%-48.7% -25.4%
From 52-week high -9.1%-38.3%-10.1% -3.2%
52-week high $110.94$26.25$60.53 $779.14
52-week low $50.69$11.79$20.49 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleLNTHPREHTFL
P/E now vs peer median 23.9xmedian 28.1x -3.2xmedian 28.1x -39.7xmedian 28.1x
P/S now vs peer median 4.2xmedian 2.9x 1.5xmedian 2.9x 22.2xmedian 2.9x
EV/EBITDA now vs peer median 16.6xmedian 18.0x -3.7xmedian 18.0x -61.0xmedian 18.0x
P/FCF now vs peer median 17.0xmedian 24.8x -5.3xmedian 24.8x -79.7xmedian 24.8x
P/B now vs peer median 5.0xmedian 2.3x 2.9xmedian 2.3x 16.9xmedian 2.3x
PEG now vs peer median 0.23median 0.95 -0.06median 0.95 —median 0.95

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsLNTHPREHTFL
Revenue $1.56B $185.92M $212.08M
Gross profit $936.02M $88.89M $169.83M
Operating income $302.34M -$64.90M -$80.25M
Net income $275.31M -$71.99M -$118.37M
Free cash flow $387.83M -$51.49M -$59.18M
R&D $173.09M $4.11M $83.84M
EPS (diluted) $4.08 $-5.06 $-1.37
Cash & equivalents $593.30M $59.05M $34.36M
Total debt $571.05M – –
Shares (diluted) 67.52M 14.05M 86.40M
Enterprise value $4.76B $88.94M $4.65B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricLNTHPREHTFL
P/E 23.9x -3.2x -39.7x
P/FCF 17.0x -5.3x -79.7x
P/Operating cash flow 15.9x -5.3x -90.3x
P/S 4.2x 1.5x 22.2x
P/B 5.0x 2.9x 16.9x
P/Tangible book 10.6x 2.9x 16.9x
EV/EBITDA 16.6x -3.7x -61.0x
EV/EBIT 21.7x -3.3x -55.7x
EV/Revenue 4.2x 1.2x 21.1x
EV/FCF 16.9x -4.2x -75.5x
EV/Operating cash flow 15.9x -4.2x -85.6x
PEG (3Y EPS CAGR) 0.23 -0.06 –

Growth

14 metrics
MetricLNTHPREHTFL
Revenue growth (1Y) 2.3% 513.0% 42.8%
Revenue CAGR (3Y) 11.4% 115.5% –
Gross profit growth (1Y) -3.4% 413.6% 51.8%
Gross profit CAGR (3Y) 16.3% 127.9% –
Operating income growth (1Y) -30.9% -78.6% -29.0%
Operating income CAGR (3Y) 118.8% -3.5% –
Net income growth (1Y) 1.6% -60.1% -26.4%
Net income CAGR (3Y) 102.1% -16.5% –
EPS growth (1Y) 5.8% -28.5% 90.8%
EPS CAGR (3Y) 105.5% 52.8% –
Operating cash flow growth (1Y) -21.7% – 19.4%
Operating cash flow CAGR (3Y) 14.5% – –
Free cash flow growth (1Y) -10.1% – 13.0%
Free cash flow CAGR (3Y) 103.0% – –

Profitability

14 metrics
MetricLNTHPREHTFL
Gross margin 60.1% 47.8% 80.1%
EBITDA margin 25.4% -31.3% -34.6%
Operating margin 19.4% -34.9% -37.8%
Pretax margin 23.3% -23.8% -55.9%
Net margin 17.7% -38.2% -55.8%
FCF margin 24.9% -27.7% -27.9%
Operating cash flow margin 26.5% -27.7% -24.6%
Return on equity 21.8% -67.3% -41.9%
Return on assets 11.6% -43.8% -34.4%
Return on invested capital 12.5% – –
Return on capital employed 14.8% -50.7% -26.7%
Asset turnover 0.7x 1.1x 0.6x
Cash conversion (OCF / net income) 1.5x 0.7x 0.4x
Stock comp / revenue 5.0% 4.0% 11.2%

Financial Health

11 metrics
MetricLNTHPREHTFL
Debt / assets 23.6% – –
Debt / equity 0.4x – –
Net debt / EBITDA -0.1x – –
Debt / FCF 1.5x – –
Liabilities / assets 45.7% 39.5% 18.8%
Equity / assets 54.3% 60.5% 81.2%
Interest coverage 15.3x – -23.2x
Current ratio 3.1x 4.0x 5.1x
Quick ratio 2.8x 1.8x 6.6x
Cash ratio 1.8x 1.6x 5.6x
Altman Z-score 5.49 – 39.60

Shareholder Returns

7 metrics
MetricLNTHPREHTFL
Dividend yield – – –
Net buyback yield 2.8% – -7.3%
Shareholder yield 2.8% 0.0% -7.3%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusLNTHPREHTFL
Forward P/E 17.5xFY2026 – –
EPS, next fiscal year $5.76FY2026 $-3.42FY2026 $-0.43FY2026
EPS growth, next FY -5.3%FY2026 – –
EPS growth, the year after +4.2% – –
Revenue, next fiscal year $1.57BFY2026 $234.43MFY2026 $261.38MFY2026
Revenue growth, next FY +1.8%FY2026 +153.7%FY2026 +48.5%FY2026
Revenue growth, the year after +12.7% +65.3% +20.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersLNTHPREHTFL
Held by institutions 100.0% 0.9% 100.0%
Institutions holding 468 1 193
Change in shares held, QoQ +3.4% – +133.0%
Institutions buying 249 0 140
Institutions selling 143 0 38
Buyers to sellers 1.74 – 3.68

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

LNTHPREHTFL
LNTH 1.00 0.10 0.13
PRE 0.10 1.00 0.19
HTFL 0.13 0.19 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, LNTH, PRE and HTFL?

Lantheus Holdings (LNTH) is the largest by market capitalisation: Lantheus Holdings (LNTH) $6.60B, Prenetics Global (PRE) $225.11M, Heartflow (HTFL) $4.90B.

Which company is growing faster?

Prenetics Global (PRE) grew revenue fastest over the trailing twelve months: Lantheus Holdings (LNTH) +2.3%, Prenetics Global (PRE) +513.0%, Heartflow (HTFL) +42.8%.

Which company is more profitable?

Lantheus Holdings (LNTH) has the highest net margin (Lantheus Holdings (LNTH) 17.7%, Prenetics Global (PRE) -38.2%, Heartflow (HTFL) -55.8%).

Which stock has performed better?

Over the past year Lantheus Holdings (LNTH) returned the most: Lantheus Holdings (LNTH) +77.4%, Prenetics Global (PRE) +19.3%, Heartflow (HTFL) +59.8%. Over five years, Lantheus Holdings (LNTH) compounded fastest (Lantheus Holdings (LNTH) +29.6%/yr, Prenetics Global (PRE) -32.4%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Lantheus Holdings (LNTH) has been the steadiest (Lantheus Holdings (LNTH) 31.9%, Prenetics Global (PRE) 79.8%, Heartflow (HTFL) 76.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, LNTH, PRE and HTFL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Lantheus Holdings (LNTH) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.